CHRONIC CYCLOSPORINE-A NEPHROTOXICITY IN HEART-TRANSPLANTATION

被引:0
|
作者
GALLEGO, E
DEVINUESA, SG
LUNO, J
AVILES, FF
DOMINGUEZ, P
PUEYO, MLM
AHIJADO, F
VALDERRABANO, F
ARCAS, R
机构
来源
NEFROLOGIA | 1991年 / 11卷 / 06期
关键词
CYCLOSPORINE-A; NEPHROTOXICITY; HEART TRANSPLANTATION;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
We studied Cyclosporine-A (CyA)-induced nephrotoxicity in 19 stable heart transplant or heart and lung transplant patients, for a mean follow-up time of 15 months (between 4 and 26 months). All of them had normal cardiac function, and none of them presented clinical or histological rejection symptoms. Mean CyA doses were, at 3 and 12 months, 5.1 +/- 0.3 mg/kg/day and 3.8 +/- 0.28 mg/kg/day, with plasma levels of 137 +/- 26 ng/ml vs with 85 +/- 16 ng/ml respectively. The following were measured prospectively: plasma creatinine (pCr), creatinine clearance (CrCl), plasma renin activity (PRA), aldosterone (A) and microalbuminuria. The glomerular filtration rate (GFR), renal plasma flow (RPF) filtration fraction (FF) were determined using isotopic methods. No meaningful changes in pCr or CrCl were noticed during the study, but there was marked decrease in GFR and RPF, isotopically measured, between 3 and 12 months of evolution: 102.5 +/- 9.8 vs 60.5 +/- 10.5 ml/min and 411.7 +/- 40.3 vs 320.5 +/- 49 ml/min respectively, with no further decrease. The FF was high during the first months, subsequently decreasing to 20% after a year of evolution. No patient showed proteinuria; microalbuminuria at 18 months was 10.4 +/- 6-mu-g/ml. After 9 months, 57.8% of patients showed hypertension in spite of a progressive decrease in PRA and A levels. Five patients who received captopril showed a clear decrease in the GFR and the FF, compared to those who did not receive it. Our data suggest that CyA-induced nephrotoxicity is not a limiting factor in middle-term heart transplant evolution when doses between 3 and 5 mg/kg/day are used. However, CrCl overestimates by more than 30% the true GFR, so neither pCr nor CrCl are good parameters for renal function evaluation in these patients. The decrease in RPF conditions a fall in GFR and glomerular hypertension, which partially compensates it during the first months. Captopril may lead to a loss in this compensation mechanism. Hypertension is frequent and seems independent of the renin-aldosterone system.
引用
收藏
页码:518 / 525
页数:8
相关论文
共 50 条
  • [1] FISH OIL AMELIORATES ESTABLISHED CYCLOSPORINE-A NEPHROTOXICITY AFTER HEART-TRANSPLANTATION
    BROUWER, RML
    WENTING, GJ
    POS, B
    MEETER, K
    SCHALEKAMP, MADH
    WEIMAR, W
    KIDNEY INTERNATIONAL, 1991, 40 (02) : 347 - 348
  • [2] CYCLOSPORINE - ASSOCIATED NEPHROTOXICITY AFTER HEART-TRANSPLANTATION
    ERRASTI, P
    HERREROS, J
    ARCAS, R
    LLORENS, R
    PURROY, A
    NEFROLOGIA, 1988, 8 : 50 - 56
  • [3] CYCLOSPORINE NEPHROTOXICITY AND CYCLOSPORINE - DIGOXIN INTERACTION PRIOR TO HEART-TRANSPLANTATION
    DORIAN, P
    CARDELLA, C
    STRAUSS, M
    DAVID, T
    EAST, S
    OGILVIE, R
    TRANSPLANTATION PROCEEDINGS, 1987, 19 (01) : 1825 - 1827
  • [4] CYCLOSPORINE-A INDUCED HEART-FAILURE AFTER ORTHOTOPIC HEART-TRANSPLANTATION
    LACZKOVICS, A
    HAVEL, M
    TEUFELSBAUER, H
    HORVATH, R
    SCHREINER, W
    WOLNER, E
    THORACIC AND CARDIOVASCULAR SURGEON, 1987, 35 (02): : 83 - 86
  • [5] CYCLOSPORINE IN HEART-TRANSPLANTATION
    HAVERICH, A
    TRANSPLANTATION PROCEEDINGS, 1992, 24 (04) : 82 - 84
  • [6] CYCLOSPORINE-A (CSA) CHRONIC NEPHROTOXICITY IN HEART-TRANSPLANT (HT)
    DEVINUESA, SG
    GALLEGO, E
    LUNO, J
    FDEZ, F
    AVILES
    DOMINGUEZ, P
    AHIJADO, F
    VALDERRABANO, F
    ARCAS, R
    KIDNEY INTERNATIONAL, 1991, 40 (02) : 370 - 371
  • [7] CYCLOSPORINE AS THE MAIN IMMUNOSUPPRESSANT IN CLINICAL HEART-TRANSPLANTATION - CORRELATION OF HEPATOTOXICITY AND NEPHROTOXICITY
    WELZ, A
    REICHART, B
    UBERFUHR, P
    KEMKES, B
    KLINNER, W
    TRANSPLANTATION PROCEEDINGS, 1984, 16 (05) : 1212 - 1213
  • [8] REDUCTION OF CYCLOSPORINE-INDUCED NEPHROTOXICITY BY CILASTATIN FOLLOWING CLINICAL HEART-TRANSPLANTATION
    MARKEWITZ, A
    HAMMER, C
    PFEIFFER, M
    ZHAN, S
    DRECHSEL, J
    REICHENSPURNER, H
    REICHART, B
    TRANSPLANTATION, 1994, 57 (06) : 865 - 870
  • [9] INTRAVENOUS CYCLOSPORINE FOR HEART-TRANSPLANTATION
    BOLMAN, RM
    CANCE, CG
    TRANSPLANTATION PROCEEDINGS, 1989, 21 (01) : 2488 - 2488
  • [10] CYCLOSPORINE-A NEPHROTOXICITY
    DIEPERINK, H
    DANISH MEDICAL BULLETIN, 1989, 36 (03): : 235 - 248